글로벌 불임 치료 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

불임 치료 시장 분석

불임은 전 세계적으로 만연한 문제입니다. 최근 보고서에 따르면, 불임 문제가 있는 여성의 25%가 불규칙한 배란을 겪고 있습니다. 흡연 인구는 불임 감소 증상을 보였습니다. 이 모든 것이 원인을 이해하고 치료를 위한 약물을 개발하기 위한 연구 및 개발 활동에 자금을 지원했습니다.

불임 치료 시장 규모

글로벌 불임 치료 시장 규모는 2023년에 17억 5천만 달러로 평가되었으며, 2031년까지 32억 5천만 달러에 도달할 것으로 예상됩니다. 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.03%입니다.

보고 범위 및 시장 세분화       

불임 치료 시장 정의

From the name itself, it is clear that infertility treatment is the treatment options available to treat an individual suffering from infertility. Infertility is a medical condition of an individual’s inability to reproduce owing to the dearth of fertile semen. Infertility occurs due to various reasons, however, this doesn’t mean that it cannot be treated or there are any dearth of alternatives.

Infertility Treatment Market Dynamics

Drivers

• The rise in the level of smoking  

Surging consumption of smoking products is directly influencing the market demand and supply. It is scientifically proven that the consumption of tobacco and tobacco related products affect the fertility level in both men and women.

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the development of drugs and novel treatment options is also bolstering the market growth rate.

• Government investments on healthcare infrastructure

The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Also, high return on investments assured by the research activities will also work in the favour of the market.

Additionally, surge in incidences of lifestyle diseases, genetic abnormalities, stress, obesity, prostate cancer, varicocele and others, surge in the personal disposable income level, rising number of fertility clinics worldwide, increasing investment for the development of advanced medical products and devices and emerging markets such as China, India, Brazil, and Mexico , positively affect the market growth rate.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, growing geriatric population base and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2024 to 2031. Additionally, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, growing awareness about in-vitro fertilization and its benefits and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges 

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and growing complexities and concerns related to assisted reproductive technology (ART) are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, high costs associated with assisted reproductive technology (ART) procedures, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2024-2031.

This infertility treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infertility treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Infertility Treatment Market

COVID-19 has had a negative impact on the market. Focus drawn away from non-essential healthcare services to meeting the demands of COVID-19 patients derailed the market growth rate. Instructions were laid down towards protecting public and hospital frontline workers from exposure to the COVID-19 infection. During this pandemic phase, a 90% drop was observed in the number of people undergoing in-vitro fertilization cycles owing to the cancellation of in-vitro fertilization treatments. All of this led to hampering the market growth rate.

Infertility Treatment Market Scope

The infertility treatment market is segmented on the basis of sex, diagnosis, drugs and techniques. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Sex

• Males
• Females
• Unexplained

Based on the sex, the infertility treatment market is segmented into males, females and unexplained.

Diagnosis

• Men Diagnostic Tests
• Women Diagnostic
• General Diagnostic Tests

Based on the diagnosis, the infertility treatment market is segmented into men diagnostic tests, women diagnostic tests, and general diagnostic tests. Men diagnostic tests is further sub segmented into semen analysis, genetic testing, testicular biopsy, and other. Women diagnostic tests is further sub segmented into hysteroscopy, laparoscopy, ovulation testing, hysterosalpingography and others. General diagnostic tests is further sub segmented into genetic testing, hormone testing, microscopic analysis, imaging, and others.

Drugs

• Clomiphene Citrate
• Letrozole
• Serophene
• Hormone Treatment
• Others

Based on the drugs, the infertility treatment market is segmented into clomiphene citrate, letrozole, serophene, hormone treatment and others.

Techniques

• Assisted Reproductive Technology (ART)
• Intrauterine Insemination
• Surgery

Based on the techniques, the infertility treatment market is segmented into assisted reproductive technology (ART), intrauterine insemination, and surgery. Surgery is further sub segmented into laparoscopic or hysteroscopic surgery, tubal surgeries and others.

Infertility Treatment Market Regional Analysis

The infertility treatment market is analysed and market size insights and trends are provided by country, sex, diagnosis, drugs and techniques as referenced above.

The countries covered in the infertility treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the infertility treatment market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, good repayment schemes by the governmental bodies, growing number of processes pertaining to drug development, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, rise in the incidences of lifestyle-related diseases, growing demand for smoking products and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The infertility treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infertility treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infertility treatment market. The data is available for historic period 2010-2020.

Infertility Treatment Market Share

The infertility treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infertility treatment market.

Infertility Treatment Market Leaders Operating in the Market Are:

• The Cooper Companies Inc. (US)
• Cook (US)
• Vitrolife (Sweden)
• Thermo Fisher Scientific, Inc. (US)
• Esco Micro Pte. Ltd. (Singapore)
• Genea Biomedx (Australia)
• IVFtech ApS (Denmark)
• FUJIFILM Irvine Scientific (US)
• The Baker Company, Inc. (US)
• Kitazato Corporation (Japan)
• Rocket Medical plc (UK)
• IHMedical A/S (Denmark)
• Hamilton Thorne Ltd. (US)
• Carl Zeiss AG (Germany)
• MedGyn Products, Inc. (US)
• DxNow, Inc. (US)
• Nidacon International AB (Sweden)
• Gynotec B.V. (Netherlands)
• SAR Healthline Pvt. Ltd. (India)
• InVitroCare Inc. (US)

Latest Developments in Infertility Treatment Market

• In 2021, CooperSurgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples
• In 2021, Hamilton Thorne Ltd. received FDA approval for the commercialization of the GYNEMED GM501, a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe
• In 2020, Genea Biomedx (Australia) collaborated with Hamilton Thorne to commercialize Genea Biomedx’s (Australia) fertility products in the US and Canada

SKU-9906